Education
About Us
Working with TipRanks
Follow Us
VFVA - ETF AI Analysis
Top Page
Vanguard U.S. Value Factor ETF (VFVA)
Rating:67Neutral
Price Target:―
Positive Factors
Low Expense Ratio
The ETF has a very low expense ratio, making it cost-effective for investors compared to similar funds.
Sector Diversification
The fund is spread across multiple sectors, including Financials, Health Care, and Technology, reducing reliance on any single industry.
Strong Year-to-Date Performance
The ETF has delivered positive returns year-to-date, indicating solid overall performance in 2023.
Negative Factors
Underperforming Top Holdings
Several top holdings, such as Target and Pfizer, have shown weak performance this year, which could drag on overall returns.
High U.S. Concentration
The ETF is heavily focused on U.S. companies, offering limited exposure to international markets and diversification.
Minimal Real Estate Exposure
The fund has very little allocation to Real Estate, which may limit its ability to benefit from growth in this sector.
VFVA vs. SPDR S&P 500 ETF (SPY)
AUM719.00M
RegionNorth America
Expense Ratio0.13%
Beta0.91
IssuerVanguard
Inception DateFeb 13, 2018
Dividend Yield2.16%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume6,856
30 Day Avg. Volume12,981
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
151.84Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering645
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VFVA Summary
The Vanguard U.S. Value Factor ETF (VFVA) focuses on investing in U.S. companies that appear undervalued based on financial metrics, aiming to capitalize on their long-term growth potential. It includes a mix of sectors like financials, healthcare, and technology, with well-known companies such as FedEx and Pfizer among its top holdings. This ETF is a good option for investors seeking diversification and a value-focused strategy, which can perform well during certain market cycles. However, new investors should be aware that the ETF’s performance can fluctuate with market conditions, and its focus on undervalued stocks may lead to slower returns during periods of rapid market growth.
How much will it cost me?The Vanguard U.S. Value Factor ETF (VFVA) has an expense ratio of 0.13%, meaning you’ll pay $1.30 per year for every $1,000 invested. This is lower than average because it is passively managed, focusing on a value-oriented strategy that keeps costs down while providing diversified exposure to undervalued stocks.
What would affect this ETF?The Vanguard U.S. Value Factor ETF (VFVA) could benefit from a strong U.S. economy, particularly if undervalued sectors like Financials, Health Care, and Consumer Cyclical experience growth. However, rising interest rates or economic slowdowns could negatively impact some of its top holdings, such as banks and consumer-focused companies, while regulatory changes in sectors like Health Care or Technology may also pose risks.
VFVA Top 10 Holdings
The Vanguard U.S. Value Factor ETF leans heavily into financials and healthcare, with names like Regeneron and Merck providing a healthy dose of optimism thanks to rising momentum and strong earnings. General Motors is also revving up performance, driven by its EV strategy and market share gains. However, the fund faces headwinds from lagging stocks like Pfizer and EOG Resources, which are grappling with weak revenue growth and bearish signals. With its U.S.-focused portfolio and value-driven approach, the ETF offers a balanced yet sector-heavy exposure that’s navigating mixed market currents.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Verizon | 0.89% | $6.24M | $172.37B | -7.89% | 72 Outperform | |
| Regeneron | 0.87% | $6.05M | $82.46B | 3.94% | 78 Outperform | |
| General Motors | 0.85% | $5.93M | $67.92B | 31.19% | 75 Outperform | |
| Merck & Company | 0.83% | $5.84M | $259.69B | 1.46% | 76 Outperform | |
| US Bancorp | 0.82% | $5.73M | $76.09B | -8.47% | 75 Outperform | |
| FedEx | 0.78% | $5.47M | $65.08B | -9.08% | 75 Outperform | |
| Truist Financial | 0.78% | $5.44M | $59.15B | -3.16% | 65 Neutral | |
| Pfizer | 0.77% | $5.42M | $146.18B | -0.46% | 68 Neutral | |
| Bristol-Myers Squibb | 0.75% | $5.21M | $100.26B | -16.90% | 69 Neutral | |
| EOG Resources | 0.73% | $5.11M | $57.62B | -20.20% | 74 Outperform |
VFVA Technical Analysis
Positive
―
Price Trends
126.71
Positive
124.91
Positive
118.74
Positive
Market Momentum
0.34
Negative
62.17
Neutral
86.94
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VFVA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 126.03, equal to the 50-day MA of 126.71, and equal to the 200-day MA of 118.74, indicating a bullish trend. The MACD of 0.34 indicates Negative momentum. The RSI at 62.17 is Neutral, neither overbought nor oversold. The STOCH value of 86.94 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VFVA.
VFVA Peer Comparison
Comparison Results
Performance Comparison
VFVA
Vanguard U.S. Value Factor ETF
130.36
4.41
3.50%
LSVD
LSV Disciplined Value ETF
―
―
―
QVAL
Alpha Architect U.S. Quantitative Value ETF
―
―
―
AIVL
WisdomTree U.S. AI Enhanced Value Fund
―
―
―
BUSA
Brandes U.S. Value ETF
―
―
―
GVLU
Gotham 1000 Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents